Summary
Immunohistology provides a necessary but insufficient criterion for selecting monoclonal antibodies (MAbs) capable of tumour targeting in vivo. Additional selection procedures have been evaluated using a panel of anti-melanoma MAbs, including immunoreactivity of (labelled) MAbs, antibody affinity, kinetics of binding and release, apparent antigen density and accumulation in nude mouse transplants. According to these criteria, MAbs M.2.7.6 and M.2.9.4 showed the most favourable properties, i.e. high immunoreactivity and pronounced internalization into melanoma cells. With MAbs M.2.10.15 and KG 6–56, moderate immunoreactivity and a binding pattern characterized by temperature dependence in the absence of internalization was observed. According to the paired label assay, all four MAbs showed specific accumulation into solid melanoma tissue. However, application in the patient still requires evaluation of the side effects of antigen cross-expression on normal human tissues.
Similar content being viewed by others
References
Bradwell AR, Fairweather DS, Dykes PW, Keeling A, Vaughan A, Taylor J (1985) Limiting factors in the localization of tumours with radiolabelled antibodies. Immunol Today 6:163
Bröcker E-B, Suter L, Brüggen J, Ruiter DJ, Macher E, Sorg C (1985) Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer 36:29
Brüggen J, Sorg C (1983) Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies. Cancer Immunol Immunother 15:200
Brüggen J, Bröcker E-B, Suter L, Redmann K, Sorg C (1984) The expression of tumor-associated antigens in primary and metastatic human malignant melanoma. Behring Inst Mitt 64:19
Capone PM, Papsidero LD, Chu TM (1984) Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J Natl Cancer Inst 72:6733
Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 15:429
Fidler IJ (1978) General considerations for studies of experimental cancer metastasis. Methods Cancer Res 15:399
Fraker PJ, Speck JC (1980) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3a, 6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849
Houghton AN, Eisinger M, Albino AP, Cairncross JG, Old LJ (1982) Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J Exp Med 156:1755
Kennel SJ, Foote LJ, Lankford PK, Johnson M, Mitchell T, Braslawsky GR (1983) Direct binding of radioiodinated monoclonal antibody to tumor cells: significance of antiboy purity and affinity for drug targeting or tumor imaging. Hybridoma 2:297
Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77
Matzku S, Kirchgeßner H, Dippold W, Brüggen W (1985) Immunoreactivity of monoclonal anti-melanoma antibodies in relation to the amount of radioactive iodine substituted to the antibody molecule. Eur J Nucl Med 11:260
Matzku S, Bröcker E-B, Brüggen J, Dippold WG, Tilgen W (1986) Modes of binding and internalization of monoclonal antibodies to human melanoma cells. Cancer Res 46:3848
Pressman D, Day ED, Blau M (1975) The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res 17:845
Suter L, Bröcker E-B, Brüggen J, Ruiter DJ, Sorg C (1983) Heterogeneity of primary and metastatic human malignant melanoma as detected with monoclonal antibodies in cryostat sections of biopsies. Cancer Immunol Immunother 16:53
Trucco M, de Petris S (1981) Determination of equilibrium binding parameters of monoclonal antibodies specific for cell surface antigens. In: Lefkovits I, Pernis B (eds) Immunological methods vol II, Academic Press, New York, p 1
Wilson BS, Imai K, Natali PG, Ferrone S (1981) Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 28:293
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matzku, S., Brüggen, J., Bröcker, EB. et al. Criteria for selecting monoclonal antibodies with respect to accumulation in melanoma tissue. Cancer Immunol Immunother 24, 151–157 (1987). https://doi.org/10.1007/BF00205593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205593